Sanaria Inc.
Records under this name other than the patents Sanaria Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 19 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,278,125 | Pharmaceutical Compositions Comprising Attenuated Plasmodium Sporozoites and Glycolipid Adjuvants Formerly held In force · High confidence | In force | High confidence | |
| US 9,642,909 | Pharmaceutical Compositions Comprising Attenuated Plasmodium Sporozoites and Glycolipid Adjuvants Formerly held In force · High confidence | In force | High confidence | |
| US 12,409,213 | Live attenuated oral vaccine against shigellosis and typhoid fever Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,781,419 | Mosquito Salivary Gland Extraction Device and Methods of Use Formerly held In force · High confidence | In force | High confidence | |
| US 10,995,980 | Cryovial storage system Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,503,819 | Apparatus and Method of Use for an Automated Mosquito Salivary Gland Extraction Device Formerly held In force · High confidence | In force | High confidence | |
| US 7,229,627 | Apparatuses and Methods for the Production of Haematophagous Organisms and Parasites Suitable for Vaccine Production Term ended Term ended May 18, 2023 · High confidence | Term ended | Term ended May 18, 2023 | High confidence |
| US 8,802,919 | Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production Term ended Term ended Apr 7, 2023 · High confidence | Term ended | Term ended Apr 7, 2023 | High confidence |
| US 10,197,577 | Serum Antibody Assay for Determining Protection from Malaria, and Pre-Erythrocytic Subunit Vaccines Formerly held Lapsed on the fee record Ended Feb 5, 2023 · High confidence | Lapsed on the fee record | Ended Feb 5, 2023 | High confidence |
| US 9,931,389 | Genetic attenuation of plasmodium by B9 gene disruption Lapsed on the fee record Ended Apr 3, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2022 | From the USPTO record |